EMCURE PHARMACEUTICALS
|
The Current P/E Ratio of EMCURE PHARMACEUTICALS is 36.53.
Share Price | ₹1,363.9 | Jul 16,2025 |
Market Cap | ₹25,845.0 Cr | |
Earnings-TTM | ₹707.5 Cr | TTM-Consolidated Results |
Price/Earnings | 36.53x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of EMCURE PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹25,845.0 Cr] as on Jul 16,2025
(/) Earnings [ ₹707.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 36.53x ]
Thus, for EMCURE PHARMACEUTICALS , the investors are currently willing to pay 36.53 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of EMCURE PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of EMCURE PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of EMCURE PHARMACEUTICALS
PE Ratio Performance Analysis for EMCURE PHARMACEUTICALS
- EMCURE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- EMCURE PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, EMCURE PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 0x.
- EMCURE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does EMCURE PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
EMCURE PHARMACEUTICALS | 707.47 | 36.53 | 25,845.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.17 | 408,091.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 82.75 | 181,302.0 |
CIPLA LTD | 5,291.05 | 22.50 | 119,038.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 61.31 | 117,170.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.42 | 105,061.0 |
MANKIND PHARMA LTD | 2,003.22 | 54.05 | 108,281.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.12 | 97,463.8 |
LUPIN LTD | 3,306.26 | 26.66 | 88,134.8 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.05 | 66,960.6 |
ABBOTT INDIA LTD | 1,414.44 | 51.35 | 72,628.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs EMCURE PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.42x |
Max industry PE | 82.75x |
Median industry PE | 36.53x |
Average industry PE | 39.17x |
You may also like the below Video Courses